Ben Carter
Ben Carter is a staff writer at P&L, covering markets, dealmaking, and public companies. He previously worked in equity research, focusing on valuation, earnings, and IPOs.
Latest
Surging GLP-1 revenues threaten the terminal value of ultra-processed food and bariatric devices
7 min read
GLP-1s Are Becoming a Healthcare Budget Line
7 min read
P&L Post Email Test Preview
1 min read
P&L Post Email Test Preview
2 min read
P&L Post Email Test Preview
2 min read
P&L Post Email Test Preview
2 min read
P&L Post Email Test Preview
2 min read
Load more
Loading more...
